Fabrice Moriaud

Fabrice Moriaud is a seasoned professional in the fields of biochemistry and drug development, currently serving as the Solutions Development Manager at Bruker BioSpin since June 2012. Prior experience includes the role of Chief Scientific Officer and Product Manager at MEDIT SA, focusing on strategy and computational fragment-based drug design from February 2005 to April 2012. Earlier positions feature a postdoctoral research role at Sanofi, specializing in ADME/Tox drug properties predictions, and a postdoctoral position at Leiden University, where research centered on biochemistry and EPR techniques. Fabrice Moriaud's academic journey includes a PhD in Physical Chemistry from Université Grenoble Alpes, complemented by a Master's thesis at the Institut de Biologie Structurale. Early research work involved the study of hyperfine interactions in biomimetic models of metalloproteins at the Commissariat a l'Energie Atomique et aux Energies Alternatives.